154 related articles for article (PubMed ID: 33288583)
1. Expression of FOXO4 Inhibits Cholangiocarcinoma Cell Proliferation
Intuyod K; Chomwong S; Thongpon P; Vaeteewoottacharn K; Pairojkul C; Pinlaor P; Pinlaor S
Anticancer Res; 2020 Dec; 40(12):6899-6905. PubMed ID: 33288583
[TBL] [Abstract][Full Text] [Related]
2. Involvement of p53 and nuclear factor-kappaB signaling pathway for the induction of G1-phase cell cycle arrest of cholangiocarcinoma cell lines by isomorellin.
Hahnvajanawong C; Ketnimit S; Pattanapanyasat K; Anantachoke N; Sripa B; Pinmai K; Seubwai W; Reutrakul V
Biol Pharm Bull; 2012; 35(11):1914-25. PubMed ID: 22972485
[TBL] [Abstract][Full Text] [Related]
3. Aspirin inhibits cholangiocarcinoma cell proliferation via cell cycle arrest in vitro and in vivo.
Shi T; Gong J; Fujita K; Nishiyama N; Iwama H; Liu S; Nakahara M; Yoneyama H; Morishita A; Nonura T; Kobara H; Okano K; Suzuki Y; Masaki T
Int J Oncol; 2021 Feb; 58(2):199-210. PubMed ID: 33491760
[TBL] [Abstract][Full Text] [Related]
4. Targeted Modulation of FAK/PI3K/PDK1/AKT and FAK/p53 Pathways by Cucurbitacin B for the Antiproliferation Effect Against Human Cholangiocarcinoma Cells.
Klungsaeng S; Kukongviriyapan V; Prawan A; Kongpetch S; Senggunprai L
Am J Chin Med; 2020; 48(6):1475-1489. PubMed ID: 32907364
[TBL] [Abstract][Full Text] [Related]
5. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines.
Tepsiri N; Chaturat L; Sripa B; Namwat W; Wongkham S; Bhudhisawasdi V; Tassaneeyakul W
World J Gastroenterol; 2005 May; 11(18):2748-53. PubMed ID: 15884115
[TBL] [Abstract][Full Text] [Related]
6. Secreted cyclophilin A mediates G1/S phase transition of cholangiocarcinoma cells via CD147/ERK1/2 pathway.
Obchoei S; Sawanyawisuth K; Wongkham C; Kasinrerk W; Yao Q; Chen C; Wongkham S
Tumour Biol; 2015 Feb; 36(2):849-59. PubMed ID: 25296734
[TBL] [Abstract][Full Text] [Related]
7. Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment.
Zhao B; Zhao H; Zhao N; Zhu XG
J Hepatobiliary Pancreat Surg; 2002; 9(4):497-502. PubMed ID: 12483273
[TBL] [Abstract][Full Text] [Related]
8. E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.
Li M; Ouyang L; Zheng Z; Xiang D; Ti A; Li L; Dan Y; Yu C; Li W
Oncol Rep; 2017 Mar; 37(3):1627-1636. PubMed ID: 28184929
[TBL] [Abstract][Full Text] [Related]
9. Anti-cancer activity of asiatic acid against human cholangiocarcinoma cells through inhibition of proliferation and induction of apoptosis.
Sakonsinsiri C; Kaewlert W; Armartmuntree N; Thanan R; Pakdeechote P
Cell Mol Biol (Noisy-le-grand); 2018 Jul; 64(10):28-33. PubMed ID: 30084792
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin and atorvastatin as inhibitors of proliferation and inducers of apoptosis in human cholangiocarcinoma cells.
Buranrat B; Senggunprai L; Prawan A; Kukongviriyapan V
Life Sci; 2016 May; 153():41-9. PubMed ID: 27098189
[TBL] [Abstract][Full Text] [Related]
11. Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells.
Aneknan P; Kukongviriyapan V; Prawan A; Kongpetch S; Sripa B; Senggunprai L
Asian Pac J Cancer Prev; 2014; 15(12):5071-6. PubMed ID: 24998588
[TBL] [Abstract][Full Text] [Related]
12. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis.
Armartmuntree N; Murata M; Techasen A; Yongvanit P; Loilome W; Namwat N; Pairojkul C; Sakonsinsiri C; Pinlaor S; Thanan R
Redox Biol; 2018 Apr; 14():637-644. PubMed ID: 29169115
[TBL] [Abstract][Full Text] [Related]
13. Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker.
Chiang KC; Yeh TS; Wu RC; Pang JS; Cheng CT; Wang SY; Juang HH; Yeh CN
Sci Rep; 2016 Oct; 6():36138. PubMed ID: 27782193
[TBL] [Abstract][Full Text] [Related]
14. The transcription factor FOXO4 is down-regulated and inhibits tumor proliferation and metastasis in gastric cancer.
Su L; Liu X; Chai N; Lv L; Wang R; Li X; Nie Y; Shi Y; Fan D
BMC Cancer; 2014 May; 14():378. PubMed ID: 24886657
[TBL] [Abstract][Full Text] [Related]
15. High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma.
Detarya M; Thaenkaew S; Seubwai W; Indramanee S; Phoomak C; Saengboonmee C; Wongkham S; Wongkham C
Life Sci; 2021 Apr; 271():119114. PubMed ID: 33513399
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest.
Samukawa E; Fujihara S; Oura K; Iwama H; Yamana Y; Tadokoro T; Chiyo T; Kobayashi K; Morishita A; Nakahara M; Kobara H; Mori H; Okano K; Suzuki Y; Himoto T; Masaki T
Int J Oncol; 2017 Dec; 51(6):1674-1684. PubMed ID: 29075786
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment.
Yothaisong S; Dokduang H; Anzai N; Hayashi K; Namwat N; Yongvanit P; Sangkhamanon S; Jutabha P; Endou H; Loilome W
Tumour Biol; 2017 Mar; 39(3):1010428317694545. PubMed ID: 28347255
[TBL] [Abstract][Full Text] [Related]
18. Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines.
Asgar MA; Senawong G; Sripa B; Senawong T
Int J Oncol; 2016 Jan; 48(1):409-20. PubMed ID: 26575528
[TBL] [Abstract][Full Text] [Related]
19. Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells.
Jinawath A; Akiyama Y; Sripa B; Yuasa Y
J Cancer Res Clin Oncol; 2007 Apr; 133(4):271-8. PubMed ID: 17294242
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
